125 related articles for article (PubMed ID: 8979005)
1. The role of angiotensin I-converting enzyme gene polymorphism in renal disease.
Schmidt S; Ritz E
Curr Opin Nephrol Hypertens; 1996 Nov; 5(6):552-5. PubMed ID: 8979005
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme gene polymorphisms in renal disease: clinically relevant?
Taal MW
Curr Opin Nephrol Hypertens; 2000 Nov; 9(6):651-7. PubMed ID: 11128428
[TBL] [Abstract][Full Text] [Related]
3. [Effect of angiotensin-converting enzyme insertion-deletion polymorphism on progression of renal and cardiovascular diseases].
Reiterová J; Tesar V; Merta M
Cas Lek Cesk; 2001 May; 140(9):267-71. PubMed ID: 11417193
[TBL] [Abstract][Full Text] [Related]
4. Insertion/deletion angiotensin converting enzyme gene polymorphism affects the microvascular structure of the kidney in patients with nondiabetic renal disease.
Teranishi M; Ono H; Ishimitsu T; Matsuoka H
J Hypertens; 1999 Mar; 17(3):351-6. PubMed ID: 10100072
[TBL] [Abstract][Full Text] [Related]
5. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme gene polymorphisms and renal disease.
Jardine AG; Padmanabhan N; Connell JM
Curr Opin Nephrol Hypertens; 1998 May; 7(3):259-64. PubMed ID: 9617555
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.
Ruggenenti P; Bettinaglio P; Pinares F; Remuzzi G
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1511-25. PubMed ID: 18550651
[TBL] [Abstract][Full Text] [Related]
8. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
Yoshida H; Mitarai T; Kawamura T; Kitajima T; Miyazaki Y; Nagasawa R; Kawaguchi Y; Kubo H; Ichikawa I; Sakai O
J Clin Invest; 1995 Nov; 96(5):2162-9. PubMed ID: 7593601
[TBL] [Abstract][Full Text] [Related]
9. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
10. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
Björck S; Blohmé G; Sylvén C; Mulec H
Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
[TBL] [Abstract][Full Text] [Related]
11. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease.
Rudnicki M; Mayer G
Pharmacogenomics; 2009 Mar; 10(3):463-76. PubMed ID: 19290794
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis.
Woo KT; Lau YK; Chan CM; Wong KS
Ann Acad Med Singap; 2008 May; 37(5):372-6. PubMed ID: 18536822
[TBL] [Abstract][Full Text] [Related]
13. ACE genotype and ACE inhibitor response in kidney disease: a perspective.
Mayer G
Am J Kidney Dis; 2002 Aug; 40(2):227-35. PubMed ID: 12148094
[TBL] [Abstract][Full Text] [Related]
14. No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis.
Schmidt S; Stier E; Hartung R; Stein G; Bahnisch J; Woodroffe AJ; Clarkson AR; Ponticelli C; Campise M; Mayer G
Am J Kidney Dis; 1995 Nov; 26(5):727-31. PubMed ID: 7485124
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin I-converting enzyme insertion/deletion polymorphism: potential significance in nephrology.
Kitamura H; Moriyama T; Izumi M; Yokoyama K; Yamauchi A; Ueda N; Kamada T; Imai E
Kidney Int Suppl; 1996 Jun; 55():S101-3. PubMed ID: 8743524
[TBL] [Abstract][Full Text] [Related]
16. Insertion/Deletion polymorphism of Angiotensin-converting enzyme as a risk factor for chronic allograft nephropathy.
Fedor R; Asztalos L; Löcsey L; Szabó L; Mányiné IS; Fagyas M; Lizanecz E; Tóth A
Transplant Proc; 2010; 42(6):2304-8. PubMed ID: 20692468
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
Hunley TE; Julian BA; Phillips JA; Summar ML; Yoshida H; Horn RG; Brown NJ; Fogo A; Ichikawa I; Kon V
Kidney Int; 1996 Feb; 49(2):571-7. PubMed ID: 8821846
[TBL] [Abstract][Full Text] [Related]
18. [Angiotensin I-converting enzyme gene polymorphism and renal disease].
Nakai K; Itoh C; Nakai K; Saito F; Ninomiya K; Sato M; Sudo M
Rinsho Byori; 1997 Nov; 45(11):1067-71. PubMed ID: 9396347
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy.
Yorioka T; Suehiro T; Yasuoka N; Hashimoto K; Kawada M
Clin Nephrol; 1995 Aug; 44(2):80-5. PubMed ID: 8529313
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism.
Narita I; Goto S; Saito N; Song J; Omori K; Kondo D; Sakatsume M; Gejyo F
J Med Genet; 2003 Dec; 40(12):e130. PubMed ID: 14684698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
